(Q64228182)

1

0 references

Wei Wang

2

0 references

Jun Du

3

0 references

Hong Li

4

0 references

Huogang Wang

5

0 references

Liangliang Huang

6

0 references

Hang Xiang

7

0 references

Jing Xie

8

0 references

Xiaoli Liu

9

0 references

Heng Li

10

0 references

Wenchu Lin

Cancer Management and Research

11

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

0 references

volume

11

0 references

page(s)

1473-1492

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 February 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The Nottingham prognostic index in primary breast cancer

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 reference

12 December 2020

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

12 December 2020

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

1 reference

12 December 2020

Mutational hotspot in exon 20 of PIK3CA in breast cancer among Singapore Chinese.

1 reference

12 December 2020

Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women

1 reference

12 December 2020

PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer

1 reference

12 December 2020

Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas

1 reference

12 December 2020

PIK3CA cancer mutations display gender and tissue specificity patterns.

1 reference

12 December 2020

Recommendations for the assessment of progression in randomised cancer treatment trials

1 reference

12 December 2020

PIK3CA mutation associates with improved outcome in breast cancer.

1 reference

12 December 2020

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

1 reference

12 December 2020

PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast

1 reference

12 December 2020

Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer

1 reference

12 December 2020

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

12 December 2020

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

12 December 2020

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups

1 reference

12 December 2020

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

1 reference

12 December 2020

The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer

1 reference

12 December 2020

Comprehensive molecular portraits of human breast tumours

1 reference

12 December 2020

The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer

1 reference

12 December 2020

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients

1 reference

12 December 2020

Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.

1 reference

12 December 2020

Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients

1 reference

12 December 2020

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

1 reference

12 December 2020

Analysis of PIK3CA mutations in breast cancer subtypes.

1 reference

12 December 2020

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing

1 reference

12 December 2020

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma

1 reference

12 December 2020

PIK3CA mutations are a predictor of docetaxel plus epirubicin neoadjuvant chemotherapy clinical efficacy in breast cancer.

1 reference

12 December 2020

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

1 reference

12 December 2020

PLC and PI3K/Akt/mTOR signalling in disease and cancer

1 reference

12 December 2020

Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing

1 reference

12 December 2020

Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women

1 reference

12 December 2020

Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer

1 reference

12 December 2020

Study of PIK3CA, BRAF, and KRAS mutations in breast carcinomas among Chinese women in Qinghai.

1 reference

12 December 2020

Cancer statistics in China, 2015.

1 reference

12 December 2020

Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer.

1 reference

12 December 2020

Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach

1 reference

12 December 2020

The High Frequency of PIK3CA Mutations in Iranian Breast Cancer Patients.

1 reference

12 December 2020

Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.

1 reference

12 December 2020

Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.

1 reference

12 December 2020

The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress

1 reference

12 December 2020

Oncogenic Roles of the PI3K/AKT/mTOR Axis

1 reference

12 December 2020

Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients.

1 reference

12 December 2020

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

1 reference

12 December 2020

Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer.

1 reference

12 December 2020

Awareness and current knowledge of breast cancer.

1 reference

12 December 2020

The prognostic value of PI3K mutational status in breast cancer: a meta-analysis

1 reference

12 December 2020

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.

1 reference

12 December 2020

Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients.

1 reference

12 December 2020

PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.

1 reference

12 December 2020

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.

1 reference

12 December 2020

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.

1 reference

12 December 2020

Precise predictive and therapeutic strategy for breast cancer

1 reference

12 December 2020